Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Research & Development: 2009-2025

Historic Research & Development for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $8.3 million.

  • Lifecore Biomedical's Research & Development fell 2.68% to $2.1 million in Q2 2025 from the same period last year, while for May 2025 it was $8.3 million, marking a year-over-year decrease of 3.70%. This contributed to the annual value of $8.3 million for FY2025, which is 3.70% down from last year.
  • Per Lifecore Biomedical's latest filing, its Research & Development stood at $8.3 million for FY2025, which was down 3.70% from $8.6 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Research & Development high stood at $8.7 million for FY2023, and its period low was $6.7 million during FY2021.
  • For the 3-year period, Lifecore Biomedical's Research & Development averaged around $8.5 million, with its median value being $8.6 million (2024).
  • Its Research & Development has fluctuated over the past 5 years, first fell by 11.84% in 2021, then climbed by 17.28% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Research & Development (Yearly) stood at $6.7 million in 2021, then rose by 17.28% to $7.8 million in 2022, then increased by 11.44% to $8.7 million in 2023, then fell by 1.84% to $8.6 million in 2024, then dropped by 3.70% to $8.3 million in 2025.